Download a Flyer (Acrobat Reader required)
Additional InformationScope And Methodology
This report focuses on the market applications of current and advanced technology to the development of monitoring and therapeutic products used in the treatment of diabetes (Type 1 and Type 2) and its major complications. It considers the options that they present, the progress that is being made in these fields, and the reception these new products are likely to experience in the marketplace. The major market effects of new diabetes monitoring products and advanced therapeutics are expected to begin to be seen in the relatively short term, that is, within two to three years. The technology trends selected in conjunction with the growing interest in diabetes, diabetic complications and their treatment present the most informative picture of advances in therapeutics for diabetes and diabetic complications, and the markets that result.
This report covers both current therapeutics and current blood glucose monitoring products, in a broad sense. It does not go into the detail of the dynamics of these various products in the marketplace, either branded (proprietary) or generic in the case of drugs. The ability to do so is limited by several factors, and is especially limited where drugs for the treatment of diabetes complications are concerned. For example, antihypertensives and vasodilators used in the treatment of diabetic complications also have broad use in non-diabetic patients. In some cases, they may also have multiple on- and off-label applications for which it is not possible to discriminate among in the marketplace. Moreover, there is mixture of branded and generic products used in the treatment of diabetes and its complications.
This report does discuss, however, the impacts that advanced technologies and applications will have on existing therapeutics markets in the whole. In general, it is the current products and technologies used in the marketplace, leaving significant unmet need, that have placed today’s market in a position that is vulnerable to new technologies and products.
Market analysis for this report considers the diabetes (Type 1 and Type 2) therapeutics and home monitoring markets, as well as the markets for drugs treating the major complications of diabetes in the seven major world healthcare markets:
- United States
- United Kingdom
This report does not consider the “downstream” effects of these complications and the needs for certain types of therapeutic equipment and drugs. For example, diabetic foot is a downstream event of peripheral vascular disease resulting from long-term diabetes. While this report discusses the treatment and prevention of peripheral vascular disease, it does not follow on to products used in the treatment of diabetic foot or any of the other sequellae of diabetic peripheral vascular complications. Some mention is made of the need for therapeutic products in this and other areas, but they are not covered in depth. In terms of diabetes home monitoring, the emphasis is on glucose monitoring because this is the major opportunity market in diabetes monitoring. There are other testing areas: ketones and microalbumin. These are not strong market opportunities, however, and represent small markets that are already well served. As a result, they are mentioned but not analyzed in detail.
The focus of the report is on pharmaceutical-based technologies and products with the potential to become first-line monitoring and therapeutic modalities specifically for Type 1 and Type 2 diabetes and their major direct, long-term complications. The analysis presented in this report is based on data from a combination of company, government, industry, institutional, and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including diabetologists, endocrinologists, internists, pathologists, research scientists, business development managers and marketing managers.
More Prescription Drugs reports by Kalorama Information
More Global Prescription Drugs reports
- Diseases & Conditions
- In Vitro Diagnostics
- Molecular Assays
- Medical Devices
- Research & Development
- Prescription Drugs
- Global Markets for Diabetes Therapeutics and Diagnostics - Focus on Europe
- Global Markets for Diabetes Therapeutics and Diagnostics - Focus on Asia
- Prefilled Syringes to 2016
- Facial Aesthetics (Botox, Dermal Fillers, Collagen Products) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
- Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017